Home
About
Overview
Sharing Data
ORCID
Help
History (40)
Oprozomib in patients with newly diagnosed multiple myeloma.
pANCA and classification resistance in ulcerative colitis.
Unconventional processive mechanics of non-muscle myosin IIB.
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
See All 40 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries. Emerg Infect Dis. 2015 Jun; 21(6):977-83.
View in:
PubMed
subject areas
Antitubercular Agents
Drug Resistance, Multiple, Bacterial
Extensively Drug-Resistant Tuberculosis
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis
authors with profiles
Charlotte Kvasnovsky